Skip to content

Intrauterine delivery of Dexamethasone for repeated implantation failure: a RCT

Intrauterine delivery of Dexamethasone for repeated implantation failure: a RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200502047261N1
Enrollment
60
Registered
2023-02-20
Start date
2019-05-22
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with repeated implantation failure.

Interventions

Intervention 1: Control group: In the control group, on days 9 and 12, normal intrauterine injection of 600µL sterile saline (5 mg / ml) is performed with a fetal transfer catheter. Intervention 2: In

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: Age under 40 years (AMH) above one At least twice the previous ART by transferring at least six grade one embryos Healthy uterine cavity in ultrasound and hysteroscopy (lack of uterine anomaly, endometrial polyp, uterine myoma) Absence of endocrinopathy and autoimmune and thrombophilic diseases Normal karyotype Absence of severe male infertility Absence of moderate or severe endometriosis Absence of a specific cause for implantation in previous ARTs Absence of hydrosalpenx

Exclusion criteria

Exclusion criteria: Age over 40 years (AMH) below one Abnormal uterine cavities on ultrasound and hysteroscopy (with uterine anomalies, endometrial polyps, uterine myomas) Endocrinopathy and autoimmune and thrombophilic diseases Abnormal karyotype Severe male infertility Existence of a specific cause of non-implantation in previous ARTs Existence of hydrosalpinx Severe or moderate endometriosis

Design outcomes

Primary

MeasureTime frame
Pregnancy. Timepoint: According to the random list, patients are divided into intervention and control groups.In both groups, after basic ultrasound on the second day of the cycle, the ART cycle begins, and ovarian stimulation information is recorded for each patient. In patients in the 9 and 12 days of intramuscular injection of dexamethasone 600µL (5mg / ml) with a fetal transfer catheter, the intervention is performed slowly.In patients with the control group, the same normal volume of sterile saline is prescribed.Both groups are followed by transvaginal ultrasound while taking ART.When at least two follicles are seen, 10,000 HCG units are injected and 36 hours later the pancreas is transplanted under vaginal ultrasound. The ultrasound is performed two weeks later and the pregnancy sac is examined. Method of measurement: Pregnancy test(ßHCG).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra sadat Khonsarian

Tehran University of Medical Sciences

hsn.khosropour@gmail.com+98 21 2296 7790

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026